Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder.

Author: EvansElizabeth A, HserYih-Ing, HuangDavid, SaxonAndrew J, YooCaroline

Paper Details 
Original Abstract of the Article :
Nationwide efforts seek to address the opioid epidemic by increasing access to medications for opioid use disorder (OUD), particularly with buprenorphine. A poorly understood challenge is that among individuals with OUD who do receive buprenorphine, many do not adhere to the pharmacotherapy long eno...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/31540607

データ提供:米国国立医学図書館(NLM)

Navigating the Complexities of Buprenorphine Treatment for Opioid Use Disorder

The opioid epidemic presents a significant challenge to public health. This study delves into the complexities of buprenorphine treatment for opioid use disorder (OUD). While increased access to medication is a crucial step, the study highlights the reality that adherence to buprenorphine treatment often falls short. Researchers employed a multisite randomized trial to identify factors associated with sustained treatment utilization over time. This research provides a valuable roadmap for improving adherence and ultimately improving outcomes for individuals struggling with OUD.

Barriers to Effective Buprenorphine Treatment: A Multifaceted Challenge

The findings reveal that access barriers and medication acceptability play a significant role in buprenorphine treatment utilization. This underscores the importance of addressing these issues to ensure effective treatment for OUD. The researchers emphasize that while medication access is crucial, it's equally important to understand and address the factors that influence patient adherence. This study sheds light on the need for a multi-pronged approach to optimize treatment outcomes.

Supporting Individuals on Their Journey to Recovery

This research highlights the importance of addressing the challenges of medication accessibility and acceptability in the context of buprenorphine treatment for OUD. By understanding these factors, we can develop strategies to improve adherence and support individuals on their path to recovery. This study serves as a reminder that the journey to recovery is complex and requires a comprehensive approach that considers the individual's needs and circumstances.

Dr.Camel's Conclusion

Just as a camel adapts to the harsh desert environment, we must adapt our strategies to effectively address the complexities of OUD. This research is like a compass, guiding us toward a better understanding of the factors that influence treatment adherence. By addressing these barriers, we can create a more supportive environment for individuals seeking to overcome opioid addiction.

Date :
  1. Date Completed 2020-09-04
  2. Date Revised 2020-11-02
Further Info :

Pubmed ID

31540607

DOI: Digital Object Identifier

NIHMS1046135

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.